Latest Articles
Mesothelin as a Diagnostic Biomarker in Endometriosis: A Cross-Sectional Study.
Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal …
Published: Nov. 28, 2025, midnight
Endometrial Stromal Cells from Endometriosis Patients Reflect Lesion-Type-Specific Heterogeneity.
Endometriosis, a disease affecting about one out of ten women, is characterized by the growth of endometrial-like tissue outside the uterine cavity. There is significant disease heterogeneity, but the pathophysiological …
Published: Nov. 28, 2025, midnight
Quarter of all ovarian cancer cases linked to endometriosis: expert - NewsNation
Quarter of all ovarian cancer cases linked to endometriosis: expert NewsNation
Published: Nov. 27, 2025, 10:47 p.m.
Best Endometriosis Care in Europe for Chronic Pelvic Pain Management - Medical Tourism Magazine
Best Endometriosis Care in Europe for Chronic Pelvic Pain Management Medical Tourism Magazine
Published: Nov. 27, 2025, 6:17 p.m.
Elite Women’s Health: Why Endometriosis Must Be a Priority - Medical Tourism Magazine
Elite Women’s Health: Why Endometriosis Must Be a Priority Medical Tourism Magazine
Published: Nov. 27, 2025, 6:12 p.m.
Why Switzerland Leads in High-Quality Endometriosis Treatment - Medical Tourism Magazine
Why Switzerland Leads in High-Quality Endometriosis Treatment Medical Tourism Magazine
Published: Nov. 27, 2025, 6:11 p.m.
Switzerland’s Most Trusted Endometriosis Specialist for Long-Term Relief - Medical Tourism Magazine
Switzerland’s Most Trusted Endometriosis Specialist for Long-Term Relief Medical Tourism Magazine
Published: Nov. 27, 2025, 6:09 p.m.
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk - Nature
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk Nature
Published: Nov. 27, 2025, 5:43 p.m.
The Download: the fossil fuel elephant in the room, and better tests for endometriosis - MIT Technology Review
The Download: the fossil fuel elephant in the room, and better tests for endometriosis MIT Technology Review
Published: Nov. 27, 2025, 1:10 p.m.
Endometriosis Treatment Market at $1.55B, 7.7% CAGR - openPR.com
Endometriosis Treatment Market at $1.55B, 7.7% CAGR openPR.com
Published: Nov. 27, 2025, 10:19 a.m.
Link copied to clipboard!